US Senator Proposes to Build New PGx Agency as Part of New Legislation | GenomeWeb
NEW YORK (GenomeWeb News) - A US Senator last week introduced the first significant piece of legislation addressing pharmacogenomics that if approved into law could have broad implications for the development of molecular diagnostics and targeted therapeutics.
 
Introduced by Illinois Senator Barack Obama last Thursday, the bill, entitled the “Genomics and Personalized Medicine Act of 2006,” would create a new federal agency to oversee personalized medicine.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.